Cancer discovery news

Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.

Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
CBE for eminent ICR researcher in Queen’s Birthday Honours

10/06/16

Professor Nazneen Rahman, a world-leading scientist from The Institute of Cancer Research, London, has been awarded a CBE in the Queen's Birthday Honours list for services to medical sciences.
Drone footage of the MR-Linac magnet being lowered into the ground
Progress with MR Linac radiotherapy machine promises a new era of personalised therapy

09/06/16

Following the delivery of a giant magnet for the groundbreaking MR Linac machine, Dr Claire Bithell considers what its completion will mean for personalised cancer therapy.
The Brookes Lawley Building at the ICR's Sutton site.
Queen awards prestigious Regius Professorship to the ICR

06/06/16

The Institute of Cancer Research, London, has been awarded a highly prestigious Regius Professorship by Her Majesty the Queen to mark her 90th Birthday.
Blood samples (Jan Chlebik for the ICR, 2011)
Testing blood metabolites could help tailor cancer treatment

03/06/16

Testing for metabolic changes in the blood could indicate whether a cancer drug is working as designed, a new study reports.
Breast epithelial cells under ER stress (Chris Bakal, 2014)
Cholesterol production could drive resistance to anti-hormone treatment in ER-positive breast cancer

01/06/16

Common breast cancers could be using a cholesterol-based molecule to evade standard anti-hormone treatments, causing patients’ disease to return, according to new research.
ICR Logo
Blood test supports use of potential new treatment for patients with stomach cancer

27/05/16

Testing cancers for ‘addiction’ to a gene that boosts cell growth can pick out patients who may respond to a targeted drug under development, a major new study reports.
Prostate cancer cells
New protein test predicts survival for advanced prostate cancer patients

25/05/16

A protein linked to prostate cancer could predict which men are likely to develop resistance to current treatments and die earlier, a new study reveals.
ICR Logo
New hope for prostate cancer screening

24/05/16

Taking samples of prostate cells from all men with a family history of prostate cancer could help to identify a significant number of new cases of the disease, according to new research.
The ICR's Sutton campus
ICR and Imperial College London set out partnership plans

20/05/16

The Institute of Cancer Research, London, and Imperial College London have agreed plans to develop a strategic partnership through the creation of a virtual Cancer Research Centre of Excellence (CRCE).
Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue)
Test for six key genes can spot aggressive breast cancer

17/05/16

Testing the activity of as few as six key genes is helping to identify women with particularly aggressive breast cancer.
Non-small cell lung cancer (photo Dr Ed Uthman-Yale Rosen-Flickr)
New target for lung cancer identified

11/05/16

Researchers have uncovered a key part of a chain reaction of signals that tell some lung cancers to grow. This new insight into a major cancer signalling pathway could prioritise new drug targets.
HER3 imaging in a mouse (photo: Dr Gabriela Kramer-Marek)
Using molecular imaging to take a snapshot of cancer and its treatment

06/05/16

Researchers at The Institute of Cancer Research, London, are investigating new ways to use molecular imaging to predict how a person will respond to cancer treatment. Liz Burtally finds out how.